XARELTO 2.5MG TABLETS 28`S
KSh 2,594.00
Indicated to reduce the risk of stroke and systemic embolism in patients with nonvalvular atrial fibrillation
20 mg PO qDay with evening meal
Limited data on efficacy of rivaroxaban and warfarin in reducing the risk of stroke and systemic embolism when warfarin therapy is well-controlled
Reviews
There are no reviews yet.